NR5A2 and central nervous system cancer: Finally, 10 candidate antigens that are expected to be used for glioma mRNA vaccine were obtained according to the association with infiltration of APCs, including NAT1, FRRS1, GTF2H2C, BRCA2, GRAP, NR5A2, ABCB4, ZNF90, ERCC6L, and ZNF813.